Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

NCT01068795 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Fetal Demise
Fetal Growth Restriction
Preeclampsia
Abruptio Placentae
Thromboembolism

Interventions

DRUG: enoxaparin

Sponsor

HaEmek Medical Center, Israel